Short sellers made some sharp moves this week. Several mid-cap stocks saw short interest spike fast, while one pet retailer remains trapped in a squeeze.
REPL (Replimune Group) saw the sharpest jump among larger names. SI as a percentage of free float leapt to 43.3% from 32.4% just seven days ago — a 10.9 percentage point surge. The clinical-stage oncology firm has limited borrow availability at just 1.2x short interest, raising squeeze risk.
Prison operator CXW (CoreCivic) delivered a different kind of shock. SI rocketed from 2.3% to 10.3% in one week — a near fivefold jump. Bears appear newly concerned after a period of minimal short interest in the name.
CHWY continues to show a slow short squeeze developing. SI sat above 115% of free float in late July. By August 12 it had fallen to 94.3%. That's still extreme — but the direction favours bulls.
WOLF shows no relief. SI climbed again to 85.2% of free float. It's up from 81% a week ago. Cost to borrow sits near 3.9% APR. Analysts have a negative return potential on the stock.
GALT carries an ORTEX short score of 90.3 — one of the highest in the market. SI stands at 77.3% of float with 24 days to cover. That combination makes it a prime squeeze candidate if any catalyst emerges.
This note is for informational purposes only and is not financial advice.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
